Table 3.
Obstetrical outcomes between reduced contact prenatal care cohort and controls
| Obstetrical outcomes | Reduced contact prenatal care (n = 90) | Control (n = 90) | p-valuea |
|---|---|---|---|
| Gestational weight gain (kg) | 8.5 ± 6.2 | 8.7 ± 10.9 | 0.85 |
| Gestational age at delivery | 39w2d ± 8d | 38w3d ± 13d | 0.001 |
| Preterm delivery | 4 (4.4) | 10 (11.1%) | 0.09 |
| Cesarean delivery | 28 (31.1%) | 33 (36.7%) | 0.61 |
| Spontaneous labor | 46 (51.1%) | 44 (48.9%) | 0.27 |
| Emergent cesarean delivery | 3 (3.3%) | 2 (2.2%) | 0.65 |
| Antepartum admission | 11 (12.2%) | 11 (12.2%) | 1.0 |
| Estimated blood loss (mL) | 446.9 ± 344.8 | 491.4 ± 467.9 | 0.47 |
| Blood transfusion | 3 (3.3%) | 2 (2.2%) | 0.65 |
| Preeclampsia | 10 (11.1%) | 15 (16.7%) | 0.28 |
| IV magnesium | 6 (6.7%) | 7 (7.8%) | 0.77 |
| Chorioamnionitis | 3 (3.3%) | 3 (3.3%) | 1.0 |
| Shoulder dystocia | 0 (0.0%) | 1 (1.1%) | 0.32 |
| Postpartum hemorrhage | 5 (5.6%) | 9 (10.0%) | 0.27 |
| Third- or fourth-degree laceration | 4 (4.4%) | 1 (1.1%) | 0.17 |
| Maternal length of stay (days) | 3.5 ± 1.3 | 3.2 ± 3.4 | 0.43 |
| Fetal/neonatal outcomes | |||
| Fetal growth restriction | 4 (4.4%) | 9 (10.0%) | 0.15 |
| Fetal macrosomia | 3 (3.3%) | 6 (6.7%) | 0.31 |
| Neonatal birthweight (g) | 3352 ± 509 | 3206 ± 609 | 0.08 |
| 1-min APGAR | 7.9 ± 1.1 | 7.8 ± 1.4 | 0.96 |
| 5-min APGAR | 8.8 ± 0.6 | 8.9 ± 0.4 | 0.22 |
| 5-min APGAR < 7 | 2 (2.2%) | 0 (0%) | 0.16 |
| NICU admission | 7 (7.8%) | 15 (16.7) | 0.07 |
| Non-lethal anomaly | 0 (0%) | 1 (1.1%) | 0.32 |
| Intrauterine fetal demise | 0 (0%) | 3 (3.3%) | 0.08 |
| Composite morbidity | 1 (1.1%) | 8 (8.9%) | 0.017 |
| Neonatal length of stay (days) | 2.3 ± 1.0 | 4.4 ± 10.1 | 0.048 |
Bold values indicate p < 0.05
Data are represented as n (%) or mean ± standard deviation
aP-values were calculated by t-test or Chi-square as appropriate